The November 4, 2013, announcement by the Department of Justice that J&J will pay more than $2 Billion to settle civil and criminal claims against it reflects the severity of the damage done to patients and society’s demand that pharmaceutical companies follow regulations, according to plaintiffs’ attorney Derek T. Braslow of Pogust Millrood.
Pennsylvania attorney Derek T. Braslow said today that untold numbers of people will benefit from the agreement forged by the federal government with pharmaceutical giant Johnson & Johnson to settle criminal and civil claims about the way it marketed prescription drugs Risperdal, Invega and Natrecor.
“For years Johnson & Johnson earned profits from allegedly promoting drugs for uses which were not approved, harming the most vulnerable members in our society, children and the elderly, rather than helping them,” said Braslow. “In states across the nation, courts have heard the victims’ stories. Finally, J&J has been forced to listen to the voice of Justice.”